Innate Pharma SA (IPHA)
2.305
-0.72
(-23.68%)
USD |
NASDAQ |
Dec 16, 16:00
2.39
+0.08
(+3.69%)
After-Hours: 20:00
Innate Pharma Total Assets (Quarterly): 162.39M for June 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| DBV Technologies SA | 93.06M |
| Cellectis SA | 395.88M |
| Genfit SA | 192.20M |
| Inventiva SA | 42.26M |
| Nanobiotix SA | 92.91M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 131.52M |
| Shareholders Equity (Quarterly) | 30.87M |
| Debt to Equity Ratio | 1.233 |
| Current Ratio | 2.920 |
| Net Debt Paydown Yield | 1.26% |